Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients-Reference-Cited by-同舟云学术

Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients

Author:

Farolfi Alberto¹,Silimbani Paolo²,Gallegati Davide³,Petracci Elisabetta⁴,Schirone Alessio¹,Altini Mattia⁵,Masini Carla²

Affiliation:

1. Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

2. Oncology Pharmacy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

3. Financial and Management Control, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

4. Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

5. Healthcare Administration, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献